The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. - Wikidata - awgldk - TriplyDB

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

http://www.wikidata.org/entity/Q38003049

about

Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation Modern approaches to incompatible kidney transplantation Cell therapy to induce allograft tolerance: time to switch to plan B?Issues in solid-organ transplantation in children: translational research from bench to bedside.Unraveling the Role of Allo-Antibodies and Transplant Injury Fcγ Receptors in Solid Organ Transplantation Long-term outcomes of children after solid organ transplantation Desensitization: Overcoming the Immunologic Barriers to Transplantation IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection Endothelial cell antibodies associated with novel targets and increased rejection.Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19+CD24hiCD38hi Regulatory B-Lymphocytes Markers of Endothelial-to-Mesenchymal Transition: Evidence for Antibody-Endothelium Interaction during Antibody-Mediated Rejection in Kidney Recipients B Cells, Antibodies, and More.The clinical impact of humoral immunity in pediatric renal transplantation.Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model.Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation.Impact of preformed donor-specific antibodies against HLA class I on kidney graft outcomes: Comparative analysis of exclusively anti-Cw vs anti-A and/or -B antibodies.Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection.Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.B-cell regulation and its application to transplantation.Is it time to give up with calcineurin inhibitors in kidney transplantation?Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation.B-cell-mediated strategies to fight chronic allograft rejection Detection of donor-specific antibodies in kidney transplantation.Potential and limitations of regulatory T-cell therapy in solid organ transplantation.Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation.Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection.B-cell biomarkers in transplantation--from genes to therapy.Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction.Achieving incompatible transplantation through desensitization: current perspectives and future directions.

P2860

Q26863724-27957C34-9B5D-493C-87C5-737D1AC276AC Q27010224-3D4AB9DB-F878-48B9-9698-612194C32B89 Q27013040-964A74C6-B9BF-4D51-A216-1030817180A9 Q27023312-00EAFECF-4DB8-45DD-BB39-8BF521817165 Q28069336-A8FD12CA-BA44-42A3-B00B-9521230B8175 Q28076012-023D670C-D056-4506-B598-B1E63BC53CF2 Q28660815-16769202-C335-438B-97A4-A4C84B04B11E Q30397952-C9940145-4950-46BA-9E13-22A849EDB4B2 Q33586165-729E527B-B032-4E0F-9040-5A4A10D20370 Q34106643-092179A5-3348-4EBE-ADCF-8FE515BF91F0 Q34427661-67C9DA66-0C83-47DA-BFA0-2EFECE1B5E63 Q34483895-0BC6C761-B559-4D13-9B36-B85263373C3F Q34753440-50A27A8D-7D94-4C43-BD57-E299ADE71479 Q35027253-D764648C-C12C-4B1A-811F-6DF0A66164F0 Q35332072-F76DFF70-5038-4CFB-8231-5CF88F419EA6 Q35550551-9C1E4873-32FF-42BA-AF0C-1BD0BCDC0D81 Q35586614-C856C363-D939-499B-A978-8A3765D0A825 Q35979565-F1737476-E5CB-4E36-A537-87AE93BE57B2 Q36417863-BEC993F6-9C25-40F7-B7B8-6CE1997C587C Q36432935-C38502FE-EF89-425A-BB78-432F0B9DC1E1 Q36719246-51D3DF6E-60CD-46F3-AA1C-6A2FFD2F2751 Q37196119-3C68A5B4-AF58-4C74-838C-59C110D597BA Q37252758-5F1AA6BB-929F-4A31-8219-565FEE4E899A Q37375622-80F642B5-4795-4095-B03B-A37C491ECA70 Q37522592-169876E2-DE18-41DE-84EA-791F6B8EBE89 Q37660263-394CF1CE-723E-4274-A8EF-0522A4A999DE Q37667779-52FD65D8-00BE-4D6B-825E-491FE9AD27E1 Q37700827-91B4AD0A-124A-4411-8DFA-9FC74B8F53CE Q38076687-75560D1A-7E74-4551-8454-2512BCA62B1F Q38126085-E7B7DF2C-3877-41B0-BB83-17CF5B1936E5 Q38156847-09E86BBD-73D9-4A20-ADE0-C343AECEF8A5 Q38168293-8E6E0F8B-E81F-4FC1-9B21-8D663A388718 Q38175026-02040349-2116-4CB6-863F-C6ABB4EB6287 Q38204851-12BE7898-1A6E-4EAF-82C4-64486D17B972 Q38235166-2B7DAE75-B512-4F29-AD0C-F1D15FB07C04 Q38262909-B4A2F64E-DD0F-4624-BD4D-D6146979FF6D Q38282840-F6EA61A8-744B-416B-BBFA-E1FCA7938EBA Q38334458-B450E661-CC9D-487C-98B9-73051D7A2414 Q38409644-7BE41BF0-1B70-456B-8283-1C4F8B8140F7 Q38445336-943B7A3F-78C3-4D07-B60D-770752FDC8BB

P2860

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

http://www.wikidata.org/entity/Q38003049

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

@en

type

label

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

@en

prefLabel

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

@en

P1433

Q38003049-FD3E1C10-2F8D-4CA0-96D7-9DD5816767F9

P1476

Q38003049-FB786BF1-65A2-41C2-9B36-C036F8A85FC4

P2093

Q38003049-6E9B3263-FA47-466E-A80E-8FB0CDBAF37D

Q38003049-AFE42DDD-9748-48D4-AE1A-071BC33BE226

Q38003049-CDEA669A-CC0A-49FE-B839-42571854DA7B

P2860

Q38003049-06F7771A-EF48-462D-BCEB-AFACDC4C7C50

Q38003049-202F88A5-71CD-4327-8FCA-72282FE56F65

Q38003049-25720BBD-59E9-42F7-8BC9-21D52DD86355

Q38003049-3925EA58-A3CF-4CE9-BD32-773F9D028A36

Q38003049-3C644975-8557-483D-9827-517D82919A68

Q38003049-4298A191-E1F7-4F9C-8548-5AAC3918A79F

Q38003049-47895464-5AD2-4523-8729-CDA29052B6E0

Q38003049-49D1070E-E604-41B9-8932-8051177DB090

Q38003049-5398A675-760C-4EC6-A257-F10DD384C809

Q38003049-5D055895-63D0-4AF3-B5AB-C85D02CD4D0F

P2888

Q38003049-23C9FC74-41FF-4266-B255-B88112C7F2B8

P304

Q38003049-1C27543D-D23F-43C2-A5DB-878A664000B9

P31

Q38003049-919D4EB4-813E-489E-9C31-2E74B65F1D0F

P356

Q38003049-0D089B95-3F92-48D5-9E5F-C96DBC463550

P407

Q38003049-4174225F-6516-4F65-A53C-F97726E140DD

P433

Q38003049-4D86B628-6FAE-473D-9238-A1BA63AC95CD

P478

Q38003049-32736DBB-696F-41BE-B6A5-444C02FC545E

P577

Q38003049-5D773D3A-9BB3-4F49-9B46-29846ED116A1

P5875

Q38003049-8B7D65D2-79D6-4205-8C32-434C2FC81EA1

P698

Q38003049-1AD664DB-BCDA-403C-A634-0BA008B24C4C

P921

Q38003049-736B46A0-063C-484F-BF67-7F86C903F5AD

P356

P1433

Nature Reviews Nephrology

P1476

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

@en

P2093

Alexandre Loupy

http://www.w3.org/2001/XMLSchema#string

Gary S Hill

http://www.w3.org/2001/XMLSchema#string

Stanley C Jordan

http://www.w3.org/2001/XMLSchema#string

P2860

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Chronic progressive calcineurin nephrotoxicity: an overstated concept.

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis.

A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody

Banff 2011 Meeting report: new concepts in antibody-mediated rejection

The spectrum of antibody-mediated renal allograft injury: implications for treatment.

Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival.

Pathology of chronic humoral rejection.

Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.

P2888

P304

348-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEPH.2012.81

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224052139

http://www.w3.org/2001/XMLSchema#string

P698

22508180

http://www.w3.org/2001/XMLSchema#string

P921